G42 Healthcare, NanoScent to develop COVID-19 detector from exhaled nasal air

G42 Healthcare, NanoScent to develop COVID-19 detector from exhaled nasal air

UAE, Israel firms to collaborate on breakthrough solution to detect COVID-19 in 30 to 60 seconds. Twitter photo



G42 Healthcare, a subsidiary of Abu Dhabi-based technology company Group 42 (G42), announced on Wednesday it has signed a Memorandum of Understanding with NanoScent, an Israeli company specialised in scent reading technologies, to explore collaborations in the development, validation, distribution and manufacturing of Scent Check, a revolutionary solution capable of detecting suspected cases of COVID-19